{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004235488359299.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Jun‐Ichi Furusawa"}],"foaf:familyName":[{"@value":"Furusawa"}],"foaf:givenName":[{"@value":"Jun‐Ichi"}]}],"career":[{"institution":{"notation":[{"@value":"Department of Immunoregulation Institute of Medical Science Tokyo Medical University Tokyo Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004235488359552","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1111/cas.12731"},{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcas.12731"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12731"},{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cas.12731"},{"@type":"PMID","@value":"26132605"}],"notation":[{"@value":"Potential clinical application of interleukin‐27 as an antitumor agent"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/cas.12731_OSeV51z6UgG0o9GWTeS7Ef3QL6O"}]}